Search hospitals > Colorado > Denver
Rocky Mountain Cancer Centers-Midtown
Claim this profileDenver, Colorado 80218
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
388 reported clinical trials
8 medical researchers
Summary
Rocky Mountain Cancer Centers-Midtown is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Rocky Mountain Cancer Centers-Midtown is involved with conducting 388 clinical trials across 429 conditions. There are 8 research doctors associated with this hospital, such as Nicholas DiBella, Allen L. Cohn, Peter McSweeney, MD, and Sami Diab.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
95 reported clinical trials
180 drugs studied
Allen L. CohnRocky Mountain Cancer Centers1 year of reported clinical research
Studies Colorectal Cancer
Studies Tumors
17 reported clinical trials
35 drugs studied
Peter McSweeney, MDColorado Blood Cancer Institute6 years of reported clinical research
Studies Lymphoma
Studies Leukemia
6 reported clinical trials
9 drugs studied
Sami DiabRocky Mountain Cancer Centers7 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
5 reported clinical trials
11 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers-Midtown
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Tumors
Pancreatic Cancer
Melanoma
Prostate Cancer
Bladder Cancer
Colorectal Cancer
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Giredestrant vs. Fulvestrant
for Advanced Breast Cancer
This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the investigator's choice of a CDK4/6 inhibitor (palbociclib, ribociclib or abemaciclib), in participants with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer who have developed resistance to adjuvant endocrine therapy.
Recruiting2 awards Phase 38 criteria
Inavolisib + Fulvestrant vs Alpelisib + Fulvestrant
for Breast Cancer
This is a Phase III, multicenter, randomized, open-label, global study designed to evaluate the efficacy and safety of inavolisib plus fulvestrant compared with alpelisib plus fulvestrant in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) -negative, PIK3CA-mutated, locally advanced (LA) or metastatic breast cancer (mBC), who progressed during or after cyclin dependent kinase 4/6i (CDK4/6i)-based therapy.
Recruiting2 awards Phase 310 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Midtown?
Rocky Mountain Cancer Centers-Midtown is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Rocky Mountain Cancer Centers-Midtown is involved with conducting 388 clinical trials across 429 conditions. There are 8 research doctors associated with this hospital, such as Nicholas DiBella, Allen L. Cohn, Peter McSweeney, MD, and Sami Diab.
Where is Rocky Mountain Cancer Centers-Midtown located?
The Rocky Mountain Cancer Centers-Midtown is situated at 1800 N. Williams St., Ste. 200, Denver, CO 80218. It is conveniently located near HealthOne Presbyterian St. Luke’s Medical Center and Exempla St. Joseph Hospital. For access, head east on N. Williams St. from downtown Denver and turn right into the parking lot before reaching 18th Ave.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Rocky Mountain Cancer Centers-Midtown, call (303) 388-4876. Financial counselors are on hand to assist with understanding treatment costs and establishing a financial plan. Update insurance information via their electronic form or directly contact your clinic to confirm network status with your provider.
What insurance does Rocky Mountain Cancer Centers-Midtown accept?
Rocky Mountain Cancer Centers-Midtown accepts a variety of insurance plans, including but not limited to Aetna, Anthem BCBS Colorado, Apostrophe Health, Cigna, Colorado Access, First Health, and Humana Medicare Advantage. They strive to provide access to their facilities for as many individuals as possible and are in-network for most insurance plans. It is crucial to contact both your insurance provider and the clinic to confirm network status and understand your specific coverage.
What awards or recognition has Rocky Mountain Cancer Centers-Midtown received?
Rocky Mountain Cancer Centers-Midtown, located in Denver, Colorado, is renowned for its personalized, world-class cancer care, with a remarkable 90% of patients recommending it. The center has contributed to over 100 FDA-approved cancer therapies. It provides a comprehensive range of treatments and services, including clinical research trials.